|
|
|
| Webinar: What’s Wrong with My Trial? Uncovering the Root Cause of Clinical Trial Troubles | Clinical trials often face unforeseen challenges that can derail progress and necessitate costly corrective efforts. However, many of these challenges can be avoided with proactive planning and early intervention. Explore the most critical steps companies can take to prevent trials from reaching a point of crisis and the importance of addressing systemic issues before they escalate. Click here to learn more. |
|
|
|
| Call To Include More Pregnant And Breastfeeding Women In Research | Guest Column | A conversation with Marie Teil, women of childbearing age program, UCB | In this Q&A, UCB Global Head, Women of Childbearing Age Program Marie Teil reiterates the importance of including women of childbearing age, including pregnant and breastfeeding women, in clinical research and explains why it’s a priority for UCB. |
|
|
| Comparing Patient And Practice Characteristics | White Paper | Flatiron Health | Research suggests expanding the clinical research footprint among practices with low research engagement could help address persistent inequities in cancer clinical trial representation. |
|
|
| The Impact Of FDORA On Clinical Trial Diversity | Article | Elligo Health Research | FDORA has reshaped the clinical trial industry's focus on diversity, requiring diversity action plans and encouraging innovative strategies like DCTs and diversity-based site selection. |
|
|
|
|
| Enable Greater Diversity In Clinical Trials | Datasheet | Medidata AI | Discover how to seamlessly integrate a broad range of leading industry solutions to create an innovative, patient-centered approach that caters to specific diversity and clinical trial requirements. |
|
|
| Jumo Health Oncology Expertise | Brochure | Jumo Health | Our committed team includes medical writers, designers, health literacy experts, and oncology specialists who support a broad array of oncology clinical trials, including those targeting rare tumors. |
|
|
|
|
|
|
|
| BeiGene Moves Fast, Stays In-House To Conduct Its Cancer Clinical Trials | Guest Column | A conversation with Mark Lanasa, MD, Ph.D., BeiGene | Mark Lanasa, MD, Ph.D. explains how BeiGene gets medicines to more patients, in part by an ability to realize strategic cost and time advantages of a unique (and fast) R&D approach and by bringing clinical operations in-house. |
|
|
|
CHOOSE YOUR OWN ADVENTURE |
|
|
|
| You're receiving the Monday edition of the Clinical Leader newsletter, focusing on Clinical Sites, Patient Centricity, and Patient Recruitment. To make changes to your newsletter selections, update your topic preferences. - Clinical Sites | Patient Centricity | Patient Recruitment (Monday)
- Clinical Trial Technology (Tuesday)
- Decentralized Trials | Trial Management (Wednesday)
- Outsourcing Models | Regulatory & Compliance (Thursday)
- Clinical Data Management & Analytics | Trial Monitoring (Friday)
Learn more about our personalized newsletters here. |
|
|
Connect With Clinical Leader: |
|
|
|